Transcatheter Aortic Valve Replacement: Current Status and Future IndicationsManish Vinayak, Sahil Khera, Pier Pasquale Leone et al.|Journal of Clinical Medicine|2024Cited by 29
Treatment of Additional Vessels During Percutaneous Coronary Intervention for Unprotected Left Main Disease: Insights From a Large Prospective RegistrySean Gilhooley, Samin K. Sharma, David Power et al.|The American Journal of Cardiology|2025Cited by 1
IMPACT OF DIABETES MELLITUS ON 1-YEAR OUTCOMES OF BIODEGRADABLE VERSUS DURABLE POLYMER DRUG ELUTING STENTS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOLLOWING ROTATIONAL ATHERECTOMY: RESULTS FROM LARGE PROSPECTIVE REGISTRYRakhee R Makhija, Samin K. Sharma, Matthew Siano et al.|Journal of the American College of Cardiology|2024Cited by 0
SHOULD ADDITIONAL VESSELS BE TREATED DURING LEFT MAIN PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM A LARGE PROSPECTIVE REGISTRYDavid Power, Samin K. Sharma, Anastasios Roumeliotis et al.|Journal of the American College of Cardiology|2024Cited by 0
Impact of diabetes mellitus on one-year outcomes of bioresorbable versus durable polymer drug-eluting stents in patients undergoing percutaneous coronary intervention following rotational atherectomy: Results from a large prospective registryMatthew Siano, Rakhee R Makhija, Neelkumar Patel et al.|American Heart Journal Plus Cardiology Research and Practice|2025Cited by 0